Amedeo Smart

Free Medical Literature Service


 

Amedeo

Alzheimer's Disease

  Free Subscription

Articles published in
BMC Neurol
    December 2024
  1. QIAO M, Wu H, Chi L, Yao Q, et al
    A fatal familial insomnia patient initially misdiagnosed as Alzheimer's disease: a case report.
    BMC Neurol. 2024;24:489.
    >> Share

  2. SIRIPAOPRADIT Y, Chatsirisakul O, Ariyapaisalkul T, Sereemaspun A, et al
    Exploring the gut-brain axis in alzheimer's disease treatment via probiotics: evidence from animal studies-a systematic review and meta-analysis.
    BMC Neurol. 2024;24:481.
    >> Share

  3. DEVULDER A, Vanderlinden G, Cleeren E, Goovaerts V, et al
    A case report about focal status epilepticus as first presentation in Alzheimer's disease: finding the culprit.
    BMC Neurol. 2024;24:478.
    >> Share

    November 2024
  4. WANG W, Zhang J, Zhang M, Zhang C, et al
    Impact of diabetes mellitus on the risk of Alzheimer's disease: a mendelian randomization study.
    BMC Neurol. 2024;24:448.
    >> Share

  5. ZAMAN Z, Islam R, Koganti B, Falki V, et al
    Highly prevalent geriatric medications and their effect on beta-amyloid fibril formation.
    BMC Neurol. 2024;24:445.
    >> Share

    October 2024
  6. AKHGARJAND C, Hashemi R, Amini M, Rasekhi H, et al
    The relationship between micronutrients and cognitive ability in an elderly population with mild cognitive impairment and Alzheimer's disease: a cross-sectional study.
    BMC Neurol. 2024;24:416.
    >> Share

  7. ARIAEI A, Ghorbani A, Habibzadeh E, Moghaddam N, et al
    Investigating the association between the GAP-43 concentration with diffusion tensor imaging indices in Alzheimer's dementia continuum.
    BMC Neurol. 2024;24:397.
    >> Share

    September 2024
  8. RAJI CA, Meysami S, Porter VR, Merrill DA, et al
    Diagnostic utility of brain MRI volumetry in comparing traumatic brain injury, Alzheimer disease and behavioral variant frontotemporal dementia.
    BMC Neurol. 2024;24:337.
    >> Share

    July 2024
  9. HU Q, Shi M, Li Y, Zhao X, et al
    Elevated plasma neurofilament light was associated with multi-modal neuroimaging features in Alzheimer's disease signature regions and predicted future tau deposition.
    BMC Neurol. 2024;24:236.
    >> Share

    June 2024
  10. ZHU W, Zhou X, Ren M, Yin W, et al
    Process approach as a cognitive biomarker related to gray matter volume in mild cognitive impairment and Alzheimer's disease.
    BMC Neurol. 2024;24:199.
    >> Share

    April 2024
  11. ALTY J, Goldberg LR, Roccati E, Lawler K, et al
    Development of a smartphone screening test for preclinical Alzheimer's disease and validation across the dementia continuum.
    BMC Neurol. 2024;24:127.
    >> Share

  12. LANE RM, Darreh-Shori T, Junge C, Li D, et al
    Onset of Alzheimer disease in apolipoprotein varepsilon4 carriers is earlier in butyrylcholinesterase K variant carriers.
    BMC Neurol. 2024;24:116.
    >> Share

  13. SVENSSON JE, Bolin M, Thor D, Williams PA, et al
    Evaluating the effect of rapamycin treatment in Alzheimer's disease and aging using in vivo imaging: the ERAP phase IIa clinical study protocol.
    BMC Neurol. 2024;24:111.
    >> Share

    March 2024
  14. SHEN M, Zhang L, Chen C, Wei X, et al
    Investigating the causal relationship between immune cell and Alzheimer's disease: a mendelian randomization analysis.
    BMC Neurol. 2024;24:98.
    >> Share

  15. KWAK S, Kim H, Kim KY, Oh DY, et al
    Neuroanatomical and neurocognitive correlates of delusion in Alzheimer's disease and mild cognitive impairment.
    BMC Neurol. 2024;24:89.
    >> Share

    February 2024
  16. RAJENDRAKUMAR AL, Arbeev KG, Bagley O, Yashin AI, et al
    The SNP rs6859 in NECTIN2 gene is associated with underlying heterogeneous trajectories of cognitive changes in older adults.
    BMC Neurol. 2024;24:78.
    >> Share

  17. YE S, Roccati E, Wang W, Zhu Z, et al
    Leading determinants of incident dementia among individuals with and without the apolipoprotein E epsilon4 genotype: a retrospective cohort study.
    BMC Neurol. 2024;24:71.
    >> Share

    January 2024
  18. YANG X, Gan J, Ji Y
    Association between cerebrospinal fluid pressure and cognition in patients with Alzheimer's disease and Lewy body dementia.
    BMC Neurol. 2024;24:35.
    >> Share

    December 2023
  19. ZHU XC, Tang BF, Zhu MZ, Lu J, et al
    Analysis of complement system and its related factors in Alzheimer's disease.
    BMC Neurol. 2023;23:446.
    >> Share

    November 2023
  20. BUONGIORNO M, Granell E, Caruana G, Sansa G, et al
    Impairments in sleep and brain molecular clearance in people with cognitive deterioration and biological evidence of AD: a report of four cases.
    BMC Neurol. 2023;23:417.
    >> Share

  21. DIBELLO JR, Lu Y, Swartz J, Bortnichak EA, et al
    Patterns of use of symptomatic treatments for Alzheimer's disease dementia (AD).
    BMC Neurol. 2023;23:400.
    >> Share

    October 2023
  22. LI Z, Wu H, Luo Y, Tan X, et al
    Correction: Correlation of serum complement factor 5a level with inflammatory response and cognitive function in patients with Alzheimer's disease of different severity.
    BMC Neurol. 2023;23:347.
    >> Share

    September 2023
  23. SAHRAI H, Norouzi A, Hamzehzadeh S, Majdi A, et al
    SIMOA-based analysis of plasma NFL levels in MCI and AD patients: a systematic review and meta-analysis.
    BMC Neurol. 2023;23:331.
    >> Share

  24. LI Z, Wu H, Luo Y, Tan X, et al
    Correlation of serum complement factor 5a level with inflammatory response and cognitive function in patients with Alzheimer's disease of different severity.
    BMC Neurol. 2023;23:319.
    >> Share

    August 2023
  25. AHMADZADEH M, Christie GJ, Cosco TD, Arab A, et al
    Neuroimaging and machine learning for studying the pathways from mild cognitive impairment to alzheimer's disease: a systematic review.
    BMC Neurol. 2023;23:309.
    >> Share

  26. CROWELL V, Reyes A, Zhou SQ, Vassilaki M, et al
    Disease severity and mortality in Alzheimer's disease: an analysis using the U.S. National Alzheimer's Coordinating Center Uniform Data Set.
    BMC Neurol. 2023;23:302.
    >> Share

  27. MAZZEO S, Lassi M, Padiglioni S, Vergani AA, et al
    PRedicting the EVolution of SubjectIvE Cognitive Decline to Alzheimer's Disease With machine learning: the PREVIEW study protocol.
    BMC Neurol. 2023;23:300.
    >> Share

  28. VAN DE SANDE N, Ramakers IHGB, Visser PJ, Verhey FRJ, et al
    Tear biomarkers for Alzheimer's disease screening and diagnosis (the TearAD study): design and rationale of an observational longitudinal multicenter study.
    BMC Neurol. 2023;23:293.
    >> Share

    May 2023
  29. ZHANG J, Zheng X, Zhao Z
    A systematic review and meta-analysis on the efficacy outcomes of selective serotonin reuptake inhibitors in depression in Alzheimer's disease.
    BMC Neurol. 2023;23:210.
    >> Share

  30. BROWN CW, Chen HY, Panegyres PK
    Electroencephalography in young onset dementia.
    BMC Neurol. 2023;23:202.
    >> Share

    April 2023
  31. SISODIA V, Swinnen BEKS, Dijk JM, Verwijk E, et al
    Protocol of a randomized controlled trial investigating Deep Brain Stimulation for MOtor symptoms in patients with Parkinson's disease DEmentia (DBS-MODE).
    BMC Neurol. 2023;23:160.
    >> Share

    February 2023
  32. FU J, Lai X, Huang Y, Bao T, et al
    Meta-analysis and systematic review of peripheral platelet-associated biomarkers to explore the pathophysiology of alzheimer's disease.
    BMC Neurol. 2023;23:66.
    >> Share

    December 2022
  33. HEYRANI R, Sarabi-Jamab A, Grafman J, Asadi N, et al
    Limits on using the clock drawing test as a measure to evaluate patients with neurological disorders.
    BMC Neurol. 2022;22:509.
    >> Share

  34. TANG L, Wang ZB, Ma LZ, Cao XP, et al
    Dynamic changes of CSF clusterin levels across the Alzheimer's disease continuum.
    BMC Neurol. 2022;22:508.
    >> Share

  35. TOMASSEN J, den Braber A, van der Lee SJ, Reus LM, et al
    Amyloid-beta and APOE genotype predict memory decline in cognitively unimpaired older individuals independently of Alzheimer's disease polygenic risk score.
    BMC Neurol. 2022;22:484.
    >> Share

    September 2022
  36. GAN J, Chen Z, Liu S, Shi Z, et al
    The presence and co-incidence of geriatric syndromes in older patients with mild-moderate Lewy body dementia.
    BMC Neurol. 2022;22:355.
    >> Share

    July 2022
  37. ALTY J, Bai Q, Li R, Lawler K, et al
    The TAS Test project: a prospective longitudinal validation of new online motor-cognitive tests to detect preclinical Alzheimer's disease and estimate 5-year risks of cognitive decline and dementia.
    BMC Neurol. 2022;22:266.
    >> Share

    June 2022
  38. GUO M, Jia J, Zhang J, Zhou M, et al
    Association of beta-cell function and cognitive impairment in patients with abnormal glucose metabolism.
    BMC Neurol. 2022;22:232.
    >> Share

  39. HE L, Chen Z, Wang J, Feng H, et al
    Expression relationship and significance of NEAT1 and miR-27a-3p in serum and cerebrospinal fluid of patients with Alzheimer's disease.
    BMC Neurol. 2022;22:203.
    >> Share

    May 2022
  40. XIA P, Chen J, Bai X, Li M, et al
    Key gene network related to primary ciliary dyskinesia in hippocampus of patients with Alzheimer's disease revealed by weighted gene co-expression network analysis.
    BMC Neurol. 2022;22:198.
    >> Share

    March 2022
  41. KHADHRAOUI E, Muller SJ, Hansen N, Riedel CH, et al
    Manual and automated analysis of atrophy patterns in dementia with Lewy bodies on MRI.
    BMC Neurol. 2022;22:114.
    >> Share

  42. HANSEN S, Keune J, Kufner K, Meister R, et al
    The congruency of neuropsychological and F18-FDG brain PET/CT diagnostics of Alzheimer's Disease (AD) in routine clinical practice: insights from a mixed neurological patient cohort.
    BMC Neurol. 2022;22:83.
    >> Share

    February 2022
  43. LIU Y, Tan MS, Wang ZT, Xu W, et al
    Caspase-1 variant influencing CSF tau and FDG PET levels in non-demented elders from the ADNI cohort.
    BMC Neurol. 2022;22:59.
    >> Share

    January 2022
  44. LIU R, Tang S, Wang Y, Dong Y, et al
    Self-reported sleep characteristics associated with dementia among rural-dwelling Chinese older adults: a population-based study.
    BMC Neurol. 2022;22:5.
    >> Share

    November 2021
  45. YANG XY, Hou XH, Bi YL, Hu H, et al
    Anaemia and cerebrospinal fluid biomarkers of Alzheimer's pathology in cognitively normal elders: the CABLE study.
    BMC Neurol. 2021;21:454.
    >> Share

  46. STROFFOLINI G, Guastamacchia G, Audagnotto S, Atzori C, et al
    Low cerebrospinal fluid Amyloid-betaeta 1-42 in patients with tuberculous meningitis.
    BMC Neurol. 2021;21:449.
    >> Share

    October 2021
  47. ZHU W, Li X, Li X, Wang H, et al
    The protective impact of education on brain structure and function in Alzheimer's disease.
    BMC Neurol. 2021;21:423.
    >> Share

  48. ZHAO LJ, Wang ZT, Ma YH, Zhang W, et al
    Associations of the cerebrospinal fluid hepatocyte growth factor with Alzheimer's disease pathology and cognitive function.
    BMC Neurol. 2021;21:387.
    >> Share

  49. WANG XL, Li L
    Cell type-specific potential pathogenic genes and functional pathways in Alzheimer's Disease.
    BMC Neurol. 2021;21:381.
    >> Share

    August 2021
  50. AXENHUS M, Bogdanovic N
    Confusion, cognitive impairment, and spinal cord compression caused by plasmacytoma: a case report.
    BMC Neurol. 2021;21:303.
    >> Share

    July 2021
  51. MOLINDER A, Ziegelitz D, Maier SE, Eckerstrom C, et al
    Validity and reliability of the medial temporal lobe atrophy scale in a memory clinic population.
    BMC Neurol. 2021;21:289.
    >> Share

  52. WANG L, Li P, Hou M, Zhang X, et al
    Construction of a risk prediction model for Alzheimer's disease in the elderly population.
    BMC Neurol. 2021;21:271.
    >> Share

    May 2021
  53. STROEHLEIN JK, Vieluf S, Zimmer P, Schenk A, et al
    Learning to play golf for elderly people with subjective memory complaints: feasibility of a single-blinded randomized pilot trial.
    BMC Neurol. 2021;21:200.
    >> Share

    April 2021
  54. QIAN S, Chen K, Guan Q, Guo Q, et al
    Performance of Mattis dementia rating scale-Chinese version in patients with mild cognitive impairment and Alzheimer's disease.
    BMC Neurol. 2021;21:172.
    >> Share

    February 2021
  55. SHIMURA H, Saiko A, Hayashi A, Hattori N, et al
    Rivastigmine improves dual-task gait velocity in patients with Alzheimer's disease.
    BMC Neurol. 2021;21:61.
    >> Share

    November 2020
  56. OSAWA A, Maeshima S, Arai H, Kondo I, et al
    Dementia with aphasia and mirror phenomenon: examination of the mechanism using neuroimaging and neuropsychological findings: a case report.
    BMC Neurol. 2020;20:425.
    >> Share

  57. YU SY, Lian TH, Guo P, Li LX, et al
    Correlations of apathy with clinical symptoms of Alzheimer's disease and olfactory dysfunctions: a cross-sectional study.
    BMC Neurol. 2020;20:416.
    >> Share

    October 2020
  58. LEE P, Kim HR, Jeong Y
    Detection of gray matter microstructural changes in Alzheimer's disease continuum using fiber orientation.
    BMC Neurol. 2020;20:362.
    >> Share

    June 2020
  59. PARK KS, Ganesh AB, Berry NT, Mobley YP, et al
    The effect of physical activity on cognition relative to APOE genotype (PAAD-2): study protocol for a phase II randomized control trial.
    BMC Neurol. 2020;20:231.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016